ArticleBMC plant biology2025
Glycyrrhiza plastid paternal inheritance and a new DNA barcode provide new strategies for molecular identification of three medicinal licorice hybrid complexes.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThe widespread hybridization and introgression of Glycyrrhiza L. medicinal plants (Glycyrrhiza uralensis Fisch., Glycyrrhiza inflata Bat., and Glycyrrhiza glabra L.) complicate their classification and identification, thereby hindering the effective utilization of medicinal resources. Therefore, this study aimed to develop an efficient identification system to distinguish the three medicinal Glycyrrhiza species and their hybrid complexes.
resultsThrough morphological analysis of 345 samples from natural hybrid zones of three medicinal Glycyrrhiza species, this study identified five representative hybrid morphological phenotypes from hybrid complexes with interspecific mosaic characteristics, providing a morphological foundation for identifying hybrid complexes. However, it still has significant limitations to rely solely on morphological traits to determine the parental origins of hybrid complexes. To address this, high-throughput sequencing of parents and progeny from artificial reciprocal cross-experiments was performed, generating eight chloroplast genomes and identifying a plastid paternal inheritance mode, Glycyrrhiza, through comparative analysis of variation sites. Additionally, the DNA barcode ndhA was screened from hypervariable regions within 12 chloroplast genomes to distinguish between the three medicinal Glycyrrhiza species. Using these findings, a new identification system incorporating ndhA, ITS, and trnH-psbA was developed to identify parents and introgression types in 52 samples. It efficiently and accurately identified the three medicinal Glycyrrhiza species and their interspecific hybridization introgression types, achieving a species resolution of 98.08%, which surpassed the two older systems (ITS + trnH-psbA + rbcL + matK and ITS + trnH-psbA + rbcL + matK + trnV-ndhC) and represents the best currently available identification method. Furthermore, phylogenetic trees were constructed using chloroplast genomes, and the new system revealed that their paternal lineage influenced the position of the hybrid complexes in the phylogenetic tree.
conclusionsIn summary, this study resolved the parent origin, species identification, and phylogenetic relationships of Glycyrrhiza hybrid complexes through morphological observations, plastid inheritance mode, high-resolution chloroplast barcode ndhA, and a novel molecular identification system. These findings enhance our understanding of hybrid complexes, facilitating the optimized utilization of resources while ensuring the medicinal material’s origin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.